U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
186421186421Study of Rubitecan in Cancer Patients With Renal or Hepatic DysfunctionCompletedNo Results AvailableTumorsDrug: Rubitecanhttps://ClinicalTrials.gov/show/NCT00113113
186422186422Mechanisms of Skin Repair by Topical EstrogenCompletedNo Results AvailableSkin WrinklingDrug: Topical 17-beta estradiol in ethanol/propylene glycol (ETOH/PG)https://ClinicalTrials.gov/show/NCT00113100
186423186423Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart NetworkCompletedHas ResultsHeart Defects, Congenital|Heart Failure, CongestiveDrug: Enalapril|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00113087
186424186424Preventing Weight Gain and Controlling Blood Pressure During Smoking Cessation in Hypertensive SmokersCompletedNo Results AvailableCardiovascular Diseases|Heart Diseases|HypertensionDrug: Nicotine Replacement Therapy|Behavioral: Diethttps://ClinicalTrials.gov/show/NCT00113074
186425186425Effect of Exercise on Elevated C-Reactive Protein Concentrations in Formerly Inactive AdultsCompletedNo Results AvailableCardiovascular Diseases|Heart Diseases|ObesityProcedure: Exercisehttps://ClinicalTrials.gov/show/NCT00113061
186426186426Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic MalignanciesTerminatedNo Results AvailableHematologic MalignanciesDrug: CAMPATH (alemtuzumab)https://ClinicalTrials.gov/show/NCT00113048
186427186427Screening Protocol to Evaluate Acid Alpha-Glucosidase (GAA) Activity and GAA Gene Mutations in Patients With Late Onset Pompe DiseaseCompletedNo Results AvailablePompe Diseasehttps://ClinicalTrials.gov/show/NCT00113035
186428186428Org 24448 to Treat Major DepressionTerminatedHas ResultsDepressionDrug: Org 24448|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00113022
186429186429Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial DiseaseCompletedNo Results AvailablePeripheral Vascular DiseaseDrug: VLTS-934https://ClinicalTrials.gov/show/NCT00113009
186430186430Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for CancerCompletedNo Results AvailableNeurotoxicity|Unspecified Adult Solid Tumor, Protocol Specific|Unspecified Childhood Solid Tumor, Protocol SpecificDrug: alpha-lipoic acid|Other: placebohttps://ClinicalTrials.gov/show/NCT00112996
186431186431Eculizumab in Treating Patients With Paroxysmal Nocturnal HemoglobinuriaCompletedNo Results AvailableLeukemiaBiological: eculizumabhttps://ClinicalTrials.gov/show/NCT00112983
186432186432Vaccine Therapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal CancerCompletedNo Results AvailableFallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity CancerBiological: fowlpox-NY-ESO-1 vaccine|Biological: recombinant vaccinia-NY-ESO-1 vaccine|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00112957
186433186433Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's LymphomaRecruitingNo Results AvailableLymphomaBiological: rituximabhttps://ClinicalTrials.gov/show/NCT00112931
186434186434Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon CancerCompletedHas ResultsColorectal CancerBiological: Bevacizumab|Drug: Capecitabine|Drug: 5-Fluorouracil (5-FU)|Drug: Leucovorin calcium|Drug: Oxaliplatinhttps://ClinicalTrials.gov/show/NCT00112918
186435186435Sorafenib in Treating Patients With Regional or Metastatic Cancer of the UrotheliumTerminatedHas ResultsAdenocarcinoma of the Bladder|Distal Urethral Cancer|Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter|Proximal Urethral Cancer|Recurrent Bladder Cancer|Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter|Recurrent Urethral Drug: sorafenib tosylate|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00112905
186436186436Irinotecan and Selenium in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDietary Supplement: selenium|Drug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00112892
186437186437Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple MyelomaWithdrawnNo Results AvailableStage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple Myeloma|Refractory Plasma Cell NeoplasmDrug: arsenic trioxide|Drug: ascorbic acid|Drug: dexamethasone|Drug: thalidomide|Procedure: anti-cytokine therapy|Procedure: antiangiogenesis therapy|Procedure: biological therapy|Procedure: chemotherapy|Procedure: drug resistance inhibition|Procedure: growth factor antagonist therapy|Procedure: non-specific immune-modulator therapyhttps://ClinicalTrials.gov/show/NCT00112879
186438186438Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma MultiformeCompletedNo Results AvailableAdult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain TumorDrug: cilengitide|Procedure: therapeutic conventional surgery|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00112866
186439186439Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNo Results AvailableAdult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute MyeloblastDrug: tipifarnib|Drug: etoposidehttps://ClinicalTrials.gov/show/NCT00112853
186440186440CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney CancerActive, not recruitingHas ResultsClear Cell Renal Cell Carcinoma|Recurrent Renal Cell Cancer|Stage IV Renal Cell CancerDrug: CCI-779|Drug: Bevacizumabhttps://ClinicalTrials.gov/show/NCT00112840
186441186441Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple MyelomaActive, not recruitingNo Results AvailableRefractory Multiple Myeloma|Smoldering Multiple Myeloma|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple MyelomaRadiation: total marrow irradiation|Drug: melphalan|Procedure: peripheral blood stem cell transplantation|Biological: filgrastim|Genetic: fluorescence in situ hybridization|Genetic: cytogenetic analysis|Drug: cyclophosphamide|Procedure: autologous-autologous tandem hematopoietic stem cell transplantation|Drug: lenalidomidehttps://ClinicalTrials.gov/show/NCT00112827
186442186442BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib MesylateActive, not recruitingNo Results AvailableLeukemiaDrug: dasatinib|Drug: imatinib mesylatehttps://ClinicalTrials.gov/show/NCT00112775
186443186443Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast CancerCompletedNo Results AvailableBreast Cancer|FatigueBiological: infliximab|Other: Clinical Assessment|Other: Self-report questionnaires|Other: Immune Assessmenthttps://ClinicalTrials.gov/show/NCT00112749
186444186444Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant GliomaCompletedHas ResultsAdult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Diffuse Astrocytoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Adult Pilocytic Astrocytoma|Adult Pineal Gland Astrocytoma|Adult Subependymal GDrug: erlotinib|Drug: temsirolimus|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00112736
186445186445Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaActive, not recruitingNo Results AvailableAdult Lymphocyte Depletion Hodgkin Lymphoma|Adult Lymphocyte Predominant Hodgkin Lymphoma|Adult Mixed Cellularity Hodgkin Lymphoma|Adult Nodular Sclerosis Hodgkin Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Extranodal MarginDrug: alvocidibhttps://ClinicalTrials.gov/show/NCT00112723
186446186446Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerRecruitingNo Results AvailableLung CancerDrug: carboplatin|Drug: cisplatin|Drug: gemcitabine hydrochloridehttps://ClinicalTrials.gov/show/NCT00112710
186447186447Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryActive, not recruitingNo Results AvailablePancreatic CancerDrug: cisplatin|Drug: docetaxel|Drug: fluorouracil|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00112697
186448186448Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid TumorsTerminatedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: alvocidib|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00112684
186449186449Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary TractCompletedHas ResultsMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter|Recurrent Bladder Cancer|Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter|Regional Transitional Cell Cancer of the Renal Pelvis and Ureter|Stage III Bladder Cancer|Stage IDrug: sorafenib tosylate|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00112671
186450186450Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic CancerActive, not recruitingNo Results AvailablePancreatic CancerDrug: fluorouracil|Drug: gemcitabine hydrochloride|Drug: irinotecan hydrochloride|Drug: leucovorin calcium|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00112658

* Görseller ve İçerik tekif hakkına sahip olabilir